Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01412333
Brief Title: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

First Submitted : August 8, 2011
First Submitted that Met QC Criteria : August 8, 2011
First Posted : August 9, 2011 (Estimate)

Results First Submitted : March 30, 2017
Results First Submitted that Met QC Criteria : July 17, 2017
Results First Posted : July 18, 2017

Certification/Extension First Submitted : October 21, 2016
Certification/Extension First Submitted that Met QC Criteria : October 25, 2016
Certification/Extension First Posted : October 26, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 15, 2020
Last Update Posted : December 17, 2020